Liu, Yan <br/><br/>
S-Adenosylmethionine synergistically enhances the antitumor effect of gemcitabine against pancreatic cancer through JAK2/STAT3 pathway.  [electronic resource] 

 -  Naunyn-Schmiedeberg's archives of pharmacology  05 2019 
 - 615-622 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Retracted Publication 
<br/><br/><label>ISSN: </label>1432-1912 
<br/><br/><label>Standard No.: </label>10.1007/s00210-019-01617-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antimetabolites, Antineoplastic--pharmacology<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Apoptosis--drug effects<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Deoxycytidine--analogs & derivatives<br/>Drug Synergism<br/>Female<br/>Humans<br/>Janus Kinase 2--metabolism<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Pancreatic Neoplasms--drug therapy<br/>S-Adenosylmethionine--pharmacology<br/>STAT3 Transcription Factor--metabolism<br/>Signal Transduction--drug effects<br/>Tumor Burden--drug effects<br/>Gemcitabine